PortfoliosLab logoPortfoliosLab logo
FF vs. MED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FF vs. MED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in FutureFuel Corp. (FF) and Medifast, Inc. (MED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FF achieves a 46.58% return, which is significantly higher than MED's 11.33% return. Over the past 10 years, FF has outperformed MED with an annualized return of 3.98%, while MED has yielded a comparatively lower -7.29% annualized return.


FF

1D
0.88%
1M
14.41%
YTD
46.58%
6M
38.76%
1Y
16.71%
3Y*
-6.25%
5Y*
-4.53%
10Y*
3.98%

MED

1D
-0.25%
1M
-4.73%
YTD
11.33%
6M
-3.80%
1Y
-8.40%
3Y*
-46.74%
5Y*
-45.89%
10Y*
-7.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FF vs. MED - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FF
FutureFuel Corp.
46.58%-35.84%31.03%-22.78%9.85%-26.86%37.61%-20.32%14.46%3.12%
MED
Medifast, Inc.
11.33%-39.39%-73.79%-38.34%-42.31%9.36%86.18%-9.73%82.11%72.33%

Correlation

The correlation between FF and MED is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Mar 23, 2011

0.28

The correlation between FF and MED shifts across timeframes, from 0.12 (1 year) to 0.28 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

FF:

$202.52M

MED:

$130.86M

EPS

FF:

-$1.19

MED:

-$1.82

PS Ratio

FF:

1.83

MED:

0.38

PB Ratio

FF:

1.43

MED:

0.66

Total Revenue (TTM)

FF:

$110.11M

MED:

$346.10M

Gross Profit (TTM)

FF:

-$26.13M

MED:

$242.70M

EBITDA (TTM)

FF:

-$50.17M

MED:

-$3.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FF vs. MED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FF
FF Risk / Return Rank: 5959
Overall Rank
FF Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
FF Sortino Ratio Rank: 5656
Sortino Ratio Rank
FF Omega Ratio Rank: 5757
Omega Ratio Rank
FF Calmar Ratio Rank: 6060
Calmar Ratio Rank
FF Martin Ratio Rank: 6060
Martin Ratio Rank

MED
MED Risk / Return Rank: 3333
Overall Rank
MED Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
MED Sortino Ratio Rank: 3030
Sortino Ratio Rank
MED Omega Ratio Rank: 3131
Omega Ratio Rank
MED Calmar Ratio Rank: 3535
Calmar Ratio Rank
MED Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FF vs. MED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for FutureFuel Corp. (FF) and Medifast, Inc. (MED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FFMEDDifference
Sharpe ratioReturn per unit of total volatility

+0.73

Sortino ratioReturn per unit of downside risk

+1.08

Omega ratioGain probability vs. loss probability

1.14

0.99

+0.14

Calmar ratioReturn relative to maximum drawdown

0.81

-0.26

+1.07

Martin ratioReturn relative to average drawdown

1.67

-0.44

+2.12

FF vs. MED - Sharpe Ratio Comparison

The current FF Sharpe Ratio is 0.50, which is higher than the MED Sharpe Ratio of -0.23. The chart below compares the historical Sharpe Ratios of FF and MED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FF vs. MED - Drawdown Comparison

The maximum FF drawdown since its inception was -64.23%, smaller than the maximum MED drawdown of -98.40%. Use the drawdown chart below to compare losses from any high point for FF and MED.


Loading charts...

Drawdown Indicators


FFMEDDifference

Max Drawdown

Largest peak-to-trough decline

-64.23%

-98.40%

+34.17%

Max Drawdown (1Y)

Largest decline over 1 year

-30.85%

-37.39%

+6.54%

Max Drawdown (3Y)

Largest decline over 3 years

-51.46%

-90.91%

+39.45%

Max Drawdown (5Y)

Largest decline over 5 years

-51.46%

-96.29%

+44.83%

Max Drawdown (10Y)

Largest decline over 10 years

-64.23%

-96.76%

+32.53%

Current Drawdown

Current decline from peak

-45.08%

-95.96%

+50.88%

Average Drawdown

Average peak-to-trough decline

-30.54%

-50.84%

+20.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.89%

21.83%

-6.94%

Volatility

FF vs. MED - Volatility Comparison

FutureFuel Corp. (FF) and Medifast, Inc. (MED) have volatilities of 9.35% and 8.94%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FFMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.35%

8.94%

+0.41%

Volatility (6M)

Calculated over the trailing 6-month period

39.19%

31.69%

+7.50%

Volatility (1Y)

Calculated over the trailing 1-year period

49.93%

41.90%

+8.03%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

46.27%

45.25%

+1.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

44.61%

47.68%

-3.07%

Dividends

FF vs. MED - Dividend Comparison

FF's dividend yield for the trailing twelve months is around 4.13%, while MED has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
FF
FutureFuel Corp.
4.13%7.52%51.80%3.95%2.95%35.86%25.51%1.94%1.51%1.70%18.20%1.78%
MED
Medifast, Inc.
0.00%0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%

Financials

FF vs. MED - Financials Comparison

This section allows you to compare key financial metrics between FutureFuel Corp. and Medifast, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M20222023202420252026
31.90M
76.04M
(FF) Total Revenue
(MED) Total Revenue
Values in USD except per share items

FF vs. MED - Profitability Comparison

The chart below illustrates the profitability comparison between FutureFuel Corp. and Medifast, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-100.0%-50.0%0.0%50.0%202220232024202520260
68.1%
Portfolio components
FF - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, FutureFuel Corp. reported a gross profit of 0.00 and revenue of 31.90M. Therefore, the gross margin over that period was 0.0%.

MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.

FF - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, FutureFuel Corp. reported an operating income of -20.84M and revenue of 31.90M, resulting in an operating margin of -65.3%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.

FF - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, FutureFuel Corp. reported a net income of -20.58M and revenue of 31.90M, resulting in a net margin of -64.5%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.


Frequently Asked Questions


FF and MED have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FF has higher volatility (9.35%) compared to MED (8.94%). In terms of maximum drawdown, FF dropped -64.23% vs MED's -98.40%.

FF currently has the higher Sharpe Ratio (0.50 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FF and MED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer